{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:34:27Z","timestamp":1790361267131,"version":"4.1.0"},"reference-count":31,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2017,6,4]],"date-time":"2017-06-04T00:00:00Z","timestamp":1496534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006388","name":"H\u00f4pitaux Universitaires de Gen\u00e8ve","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006388","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Medicine"],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cervical cancer (<jats:styled-content style=\"fixed-case\">CC<\/jats:styled-content>) is the leading cause of cancer\u2010related death among women in sub\u2010Saharan Africa, primarily because of limited access to effective screening and preventive treatment. Our aim was to assess the feasibility of a human papillomavirus (<jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>)\u2010based <jats:styled-content style=\"fixed-case\">CC<\/jats:styled-content> screen\u2010and\u2010treat approach in a low\u2010resource context. We recruited 1012 women aged 30\u201349\u00a0years through a <jats:styled-content style=\"fixed-case\">CC<\/jats:styled-content> screening campaign conducted in the District Hospital of Dschang, Cameroon. Participants performed <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content> self\u2010sampling, which was tested for high\u2010risk <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>) <jats:styled-content style=\"fixed-case\">DNA<\/jats:styled-content> using the point\u2010of\u2010care Xpert <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content> assay. All <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>\u2010positive women were invited for visual inspection with acetic acid and Lugol's iodine (<jats:styled-content style=\"fixed-case\">VIA<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">VILI<\/jats:styled-content>) to exclude <jats:styled-content style=\"fixed-case\">CC<\/jats:styled-content> or enable triage. A cervical sample for histological analysis was also collected. Women positive for <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content> 16\/18\/45 and for other <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content> with pathological <jats:styled-content style=\"fixed-case\">VIA<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">VILI<\/jats:styled-content> were selected to undergo treatment with thermocoagulation. The <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content> prevalence in the study population was 18.5% (<jats:italic>n<\/jats:italic>\u00a0=\u00a0187); of these cases, 20 (10.6%), 42 (22.3%) and 140 (74.9%) were positive for <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>16, <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>18\/45 and other <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content> types, respectively. Overall, 107\/185 (57.8%) <jats:styled-content style=\"fixed-case\">VIA<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">VILI<\/jats:styled-content> examinations were classified as pathological and 78 (42.2%) as normal. Women positive for <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>16\/18\/45 were 4.2 times more likely to harbor cervical intraepithelial neoplasia grade 2 or worse (<jats:styled-content style=\"fixed-case\">CIN<\/jats:styled-content>2+) than those with other <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content> types. The specificity of <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content> 16\/18\/45 genotypes for detection of high\u2010grade lesions among <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content> positive women was higher than that of <jats:styled-content style=\"fixed-case\">VIA<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">VILI<\/jats:styled-content> in all age groups. The sensitivity and specificity of <jats:styled-content style=\"fixed-case\">VIA<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">VILI<\/jats:styled-content> in detecting <jats:styled-content style=\"fixed-case\">CIN<\/jats:styled-content>2+ among <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content> positive women were 80% and 44%, respectively. Overall, 110\/121 screen\u2010positive women (90.9%) were eligible for, and were treated with, thermocoagulation. An <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>\u2010based screen\u2010and\u2010treat approach is feasible in a low\u2010resource context and may contribute to improving the effectiveness of <jats:styled-content style=\"fixed-case\">CC<\/jats:styled-content> prevention programs. Immediate thermocoagulation treatment for women who are <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>16\u2010 and\/or <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>18\/45\u2010positive is a practical approach for the treatment of <jats:styled-content style=\"fixed-case\">CIN<\/jats:styled-content>2+. The combination of <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>\u2010testing and <jats:styled-content style=\"fixed-case\">VIA<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">VILI<\/jats:styled-content> for <jats:styled-content style=\"fixed-case\">CC<\/jats:styled-content> screening might reduce overtreatment.<\/jats:p>","DOI":"10.1002\/cam4.1089","type":"journal-article","created":{"date-parts":[[2017,6,5]],"date-time":"2017-06-05T04:24:43Z","timestamp":1496636683000},"page":"1752-1761","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Cervical cancer screening in a low\u2010resource setting: a pilot study on an HPV\u2010based screen\u2010and\u2010treat approach"],"prefix":"10.1002","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5431-8418","authenticated-orcid":false,"given":"Margot","family":"Kunckler","sequence":"first","affiliation":[{"name":"Gynecology Division Department of Obstetrics and Gynecology University Hospitals of Geneva  Geneva Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Schumacher","sequence":"additional","affiliation":[{"name":"Gynecology Division Department of Obstetrics and Gynecology University Hospitals of Geneva  Geneva Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Kenfack","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences University of Dschang Dschang District Hospital  Dschang Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Catarino","sequence":"additional","affiliation":[{"name":"Gynecology Division Department of Obstetrics and Gynecology University Hospitals of Geneva  Geneva Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Viviano","sequence":"additional","affiliation":[{"name":"Gynecology Division Department of Obstetrics and Gynecology University Hospitals of Geneva  Geneva Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline","family":"Tincho","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Biomedical Sciences Centre Hospitalier Universitaire (CHUY)  Yaound\u00e9 Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre\u2010Marie","family":"Tebeu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Biomedical Sciences Centre Hospitalier Universitaire (CHUY)  Yaound\u00e9 Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliane","family":"Temogne","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Biomedical Sciences Centre Hospitalier Universitaire (CHUY)  Yaound\u00e9 Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Vassilakos","sequence":"additional","affiliation":[{"name":"Geneva Foundation for Medical Education and Research  Geneva Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Petignat","sequence":"additional","affiliation":[{"name":"Gynecology Division Department of Obstetrics and Gynecology University Hospitals of Geneva  Geneva Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,6,4]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr015"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2016.03.011"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa071430"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62218-7"},{"key":"e_1_2_6_6_1","first-page":"594","article-title":"Effective screening programs for cervical cancer in low\u2010 and middle\u2010 income developing countries","volume":"79","author":"Sankaranarayanan R.","year":"2001","journal-title":"Bull. World Health Organ."},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70570-9"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-14-596"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28283"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.510"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP4Q0NSDHWIZGU"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.05.071"},{"key":"e_1_2_6_13_1","first-page":"4","article-title":"Cervical cancer screening: the challenges of tracking and follow\u2010up","volume":"4","author":"Joseph N.","year":"2015","journal-title":"J. Genit. Syst. Disord."},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.17.2173"},{"key":"e_1_2_6_15_1","unstructured":"Arbyn M. P.D.Blumenthal J.Cain M.Chirenje L.Denny H.De Vuyst et\u00a0al.2013.WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention."},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0000000000000206"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcpo.2013.11.002"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601024"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.12655"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0000000000000031"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808516"},{"key":"e_1_2_6_22_1","first-page":"1","article-title":"HPV prevalence in women attending cervical screening in rural Malawi using the cartridge\u2010based Xpert HPV assay","volume":"30","author":"Cubie H. A.","year":"2016","journal-title":"J. Clin. Virol."},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2016.04.013"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.07.092"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.26147"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-015-0373-1"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2014.25.4.282"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164000"},{"key":"e_1_2_6_29_1","first-page":"145","article-title":"Cold coagulation. Baili\u00e8re's","volume":"9","author":"Duncan I. D.","year":"1995","journal-title":"Clin. Obstet. Gynaecol."},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29250"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29353"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-353"}],"container-title":["Cancer Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcam4.1089","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.1089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T19:26:09Z","timestamp":1696620369000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cam4.1089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,4]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.1002\/cam4.1089"],"URL":"https:\/\/doi.org\/10.1002\/cam4.1089","archive":["Portico"],"relation":{},"ISSN":["2045-7634","2045-7634"],"issn-type":[{"value":"2045-7634","type":"print"},{"value":"2045-7634","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,4]]},"assertion":[{"value":"2017-01-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-03-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-06-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}